JP2007506774A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007506774A5 JP2007506774A5 JP2006528249A JP2006528249A JP2007506774A5 JP 2007506774 A5 JP2007506774 A5 JP 2007506774A5 JP 2006528249 A JP2006528249 A JP 2006528249A JP 2006528249 A JP2006528249 A JP 2006528249A JP 2007506774 A5 JP2007506774 A5 JP 2007506774A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- sustained release
- release dosage
- active ingredient
- pharmaceutically active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002552 dosage form Substances 0.000 claims 82
- 238000013268 sustained release Methods 0.000 claims 72
- 239000012730 sustained-release form Substances 0.000 claims 72
- 239000004480 active ingredient Substances 0.000 claims 24
- 239000007787 solid Substances 0.000 claims 23
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims 13
- 229940079593 drug Drugs 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 11
- 239000007884 disintegrant Substances 0.000 claims 10
- 239000011230 binding agent Substances 0.000 claims 9
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 9
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 9
- 239000004094 surface-active agent Substances 0.000 claims 7
- -1 decibuprofen Chemical compound 0.000 claims 6
- 239000000463 material Substances 0.000 claims 5
- 230000003204 osmotic effect Effects 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000002736 nonionic surfactant Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 239000011248 coating agent Substances 0.000 claims 3
- 238000000576 coating method Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000002357 osmotic agent Substances 0.000 claims 3
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 claims 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical group C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- VJHCJDRQFCCTHL-UHFFFAOYSA-N acetic acid 2,3,4,5,6-pentahydroxyhexanal Chemical group CC(O)=O.OCC(O)C(O)C(O)C(O)C=O VJHCJDRQFCCTHL-UHFFFAOYSA-N 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 229960005168 croscarmellose Drugs 0.000 claims 2
- 239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 claims 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims 2
- 239000000194 fatty acid Substances 0.000 claims 2
- 229930195729 fatty acid Natural products 0.000 claims 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- 239000002563 ionic surfactant Substances 0.000 claims 2
- 229960000502 poloxamer Drugs 0.000 claims 2
- 229920001983 poloxamer Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- RJMIEHBSYVWVIN-LLVKDONJSA-N (2r)-2-[4-(3-oxo-1h-isoindol-2-yl)phenyl]propanoic acid Chemical compound C1=CC([C@H](C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-LLVKDONJSA-N 0.000 claims 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 claims 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical class [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 1
- 229920013820 alkyl cellulose Polymers 0.000 claims 1
- 229960005430 benoxaprofen Drugs 0.000 claims 1
- 229940111134 coxibs Drugs 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 claims 1
- 229960001419 fenoprofen Drugs 0.000 claims 1
- 229960002390 flurbiprofen Drugs 0.000 claims 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims 1
- 230000036571 hydration Effects 0.000 claims 1
- 238000006703 hydration reaction Methods 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 229960004187 indoprofen Drugs 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- LTRANDSQVZFZDG-SNVBAGLBSA-N naproxol Chemical compound C1=C([C@H](C)CO)C=CC2=CC(OC)=CC=C21 LTRANDSQVZFZDG-SNVBAGLBSA-N 0.000 claims 1
- 229950006890 naproxol Drugs 0.000 claims 1
- 229960002739 oxaprozin Drugs 0.000 claims 1
- OFPXSFXSNFPTHF-UHFFFAOYSA-N oxaprozin Chemical compound O1C(CCC(=O)O)=NC(C=2C=CC=CC=2)=C1C1=CC=CC=C1 OFPXSFXSNFPTHF-UHFFFAOYSA-N 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 239000000661 sodium alginate Substances 0.000 claims 1
- 235000010413 sodium alginate Nutrition 0.000 claims 1
- 229940005550 sodium alginate Drugs 0.000 claims 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50619503P | 2003-09-26 | 2003-09-26 | |
| US60/506,195 | 2003-09-26 | ||
| US57104504P | 2004-05-14 | 2004-05-14 | |
| US60/571,045 | 2004-05-14 | ||
| PCT/US2004/031475 WO2005030166A1 (en) | 2003-09-26 | 2004-09-24 | Oros push-stick for controlled delivery of active agents |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014212033A Division JP2015034168A (ja) | 2003-09-26 | 2014-10-16 | 有効成分の制御送達のためのｏｒｏｓプッシュ−スティック |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007506774A JP2007506774A (ja) | 2007-03-22 |
| JP2007506774A5 true JP2007506774A5 (OSRAM) | 2007-11-08 |
| JP5670609B2 JP5670609B2 (ja) | 2015-02-18 |
Family
ID=34396299
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006528249A Expired - Fee Related JP5670609B2 (ja) | 2003-09-26 | 2004-09-24 | 有効成分の制御送達のためのｏｒｏｓプッシュ−スティック |
| JP2014212033A Pending JP2015034168A (ja) | 2003-09-26 | 2014-10-16 | 有効成分の制御送達のためのｏｒｏｓプッシュ−スティック |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014212033A Pending JP2015034168A (ja) | 2003-09-26 | 2014-10-16 | 有効成分の制御送達のためのｏｒｏｓプッシュ−スティック |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20050089570A1 (OSRAM) |
| EP (1) | EP1663145B1 (OSRAM) |
| JP (2) | JP5670609B2 (OSRAM) |
| KR (1) | KR20060115860A (OSRAM) |
| AT (1) | ATE504288T1 (OSRAM) |
| AU (2) | AU2004275826A1 (OSRAM) |
| CA (1) | CA2540047A1 (OSRAM) |
| DE (1) | DE602004032149D1 (OSRAM) |
| IL (1) | IL174562A0 (OSRAM) |
| MX (1) | MXPA06003453A (OSRAM) |
| NO (1) | NO20061859L (OSRAM) |
| NZ (1) | NZ586198A (OSRAM) |
| WO (1) | WO2005030166A1 (OSRAM) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06003454A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada de analgesicos opioides y no opiodes. |
| CN1897924B (zh) | 2003-09-26 | 2011-09-21 | 阿尔扎公司 | 能提供高载药量的药物包衣和提供它的方法 |
| EP1765296A2 (en) * | 2004-06-30 | 2007-03-28 | Albemarle Corporation | High ibuprofen content granules and their preparation and use |
| US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
| US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
| US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
| US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
| WO2006070930A1 (en) * | 2004-12-27 | 2006-07-06 | Eisai R & D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
| US20090317355A1 (en) * | 2006-01-21 | 2009-12-24 | Abbott Gmbh & Co. Kg, | Abuse resistant melt extruded formulation having reduced alcohol interaction |
| US20100172989A1 (en) * | 2006-01-21 | 2010-07-08 | Abbott Laboratories | Abuse resistant melt extruded formulation having reduced alcohol interaction |
| US20090022798A1 (en) * | 2007-07-20 | 2009-01-22 | Abbott Gmbh & Co. Kg | Formulations of nonopioid and confined opioid analgesics |
| US8367107B2 (en) * | 2006-03-30 | 2013-02-05 | Nippon Zoki Pharmaceutical Co., Ltd. | Solid pharmaceutical preparation |
| SA07280459B1 (ar) * | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| US9744137B2 (en) | 2006-08-31 | 2017-08-29 | Supernus Pharmaceuticals, Inc. | Topiramate compositions and methods of enhancing its bioavailability |
| WO2008061226A2 (en) | 2006-11-17 | 2008-05-22 | Supernus Pharmaceuticals Inc. | Sustained-release formulations of topiramate |
| EP2061431B1 (en) * | 2006-12-04 | 2013-04-24 | Supernus Pharmaceuticals, Inc. | Enhanced immediate release formulations of topiramate |
| WO2008148798A2 (en) | 2007-06-04 | 2008-12-11 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| US8637080B2 (en) * | 2007-06-28 | 2014-01-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Rupturing controlled release device comprising a subcoat |
| JP2011511782A (ja) | 2008-02-12 | 2011-04-14 | アボット・ラボラトリーズ | 長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途 |
| CN102105136B (zh) * | 2008-03-11 | 2014-11-26 | 蒂宝制药公司 | 包含非-阿片类止痛剂和阿片类止痛剂的组合的胃滞留型缓释剂型 |
| US8372432B2 (en) * | 2008-03-11 | 2013-02-12 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| CA2751667C (en) | 2009-02-06 | 2016-12-13 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
| EP2445487A2 (en) | 2009-06-24 | 2012-05-02 | Egalet Ltd. | Controlled release formulations |
| PL399450A1 (pl) * | 2009-08-31 | 2013-01-21 | Depomed, Inc | Utrzymujace sie w zoladku kompozycje farmaceutyczne do natychmiastowego i przedluzonego uwalniania acetaminofenu |
| US9198861B2 (en) | 2009-12-22 | 2015-12-01 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| US8597681B2 (en) | 2009-12-22 | 2013-12-03 | Mallinckrodt Llc | Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans |
| US8858963B1 (en) | 2011-05-17 | 2014-10-14 | Mallinckrodt Llc | Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia |
| US8741885B1 (en) | 2011-05-17 | 2014-06-03 | Mallinckrodt Llc | Gastric retentive extended release pharmaceutical compositions |
| US9050335B1 (en) | 2011-05-17 | 2015-06-09 | Mallinckrodt Llc | Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia |
| WO2014171542A1 (ja) | 2013-04-19 | 2014-10-23 | 武田薬品工業株式会社 | 放出制御製剤 |
| WO2017155866A1 (en) * | 2016-03-07 | 2017-09-14 | SinuSys Corporation | Osmotic therapeutic agent delivery device |
| JP7014406B2 (ja) * | 2017-12-05 | 2022-02-01 | 株式会社アラクス | ロキソプロフェン含有錠剤およびその製造方法 |
| US11684596B2 (en) * | 2020-09-22 | 2023-06-27 | Elite Pharmaceuticals Solution Inc. | Antidiabetic pharmaceutical compositions and preparation method thereof |
Family Cites Families (106)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2799241A (en) * | 1949-01-21 | 1957-07-16 | Wisconsin Alumni Res Found | Means for applying coatings to tablets or the like |
| US3173876A (en) * | 1960-05-27 | 1965-03-16 | John C Zobrist | Cleaning methods and compositions |
| NL271831A (OSRAM) * | 1960-11-29 | |||
| US4034756A (en) | 1971-01-13 | 1977-07-12 | Alza Corporation | Osmotically driven fluid dispenser |
| US3995631A (en) | 1971-01-13 | 1976-12-07 | Alza Corporation | Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient |
| US3865108A (en) * | 1971-05-17 | 1975-02-11 | Ortho Pharma Corp | Expandable drug delivery device |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4111211A (en) * | 1974-05-02 | 1978-09-05 | Imperial Chemical Industries Limited | Smoking mixtures |
| US4002173A (en) * | 1974-07-23 | 1977-01-11 | International Paper Company | Diester crosslinked polyglucan hydrogels and reticulated sponges thereof |
| GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
| US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| US4008719A (en) * | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
| US4207893A (en) * | 1977-08-29 | 1980-06-17 | Alza Corporation | Device using hydrophilic polymer for delivering drug to biological environment |
| US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
| US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
| US4325236A (en) * | 1980-02-11 | 1982-04-20 | Tsui Yu Ming | Process for manufacturing regenerated leather |
| US4320759A (en) | 1980-04-28 | 1982-03-23 | Alza Corporation | Dispenser with diffuser |
| US4278087A (en) * | 1980-04-28 | 1981-07-14 | Alza Corporation | Device with integrated operations for controlling release of agent |
| US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
| US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
| US4449983A (en) * | 1982-03-22 | 1984-05-22 | Alza Corporation | Simultaneous delivery of two drugs from unit delivery device |
| GR79215B (OSRAM) * | 1982-06-07 | 1984-10-22 | Glaxo Group Ltd | |
| US4519801A (en) | 1982-07-12 | 1985-05-28 | Alza Corporation | Osmotic device with wall comprising cellulose ether and permeability enhancer |
| US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
| US4681583A (en) | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
| US4576604A (en) * | 1983-03-04 | 1986-03-18 | Alza Corporation | Osmotic system with instant drug availability |
| US4765989A (en) | 1983-05-11 | 1988-08-23 | Alza Corporation | Osmotic device for administering certain drugs |
| US4783337A (en) * | 1983-05-11 | 1988-11-08 | Alza Corporation | Osmotic system comprising plurality of members for dispensing drug |
| US4663149A (en) * | 1984-03-21 | 1987-05-05 | Alza Corporation | Dispenser comprising inner and outer walls functioning as cooperative unit |
| GB8414221D0 (en) * | 1984-06-04 | 1984-07-11 | Sterwin Ag | Unit dosage form |
| US4847077A (en) * | 1984-07-18 | 1989-07-11 | Pennwalt Corporation | Controlled release pharmaceutical preparations |
| GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
| US4763405A (en) * | 1986-08-21 | 1988-08-16 | Matsushita Electric Industrial Co., Ltd. | Chip-placement machine with test function |
| US4801461A (en) * | 1987-01-28 | 1989-01-31 | Alza Corporation | Pseudoephedrine dosage form |
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| US4806359A (en) * | 1987-04-22 | 1989-02-21 | Mcneilab, Inc. | Iburprofen sustained release matrix and process |
| US5200193A (en) * | 1987-04-22 | 1993-04-06 | Mcneilab, Inc. | Pharmaceutical sustained release matrix and process |
| US4892778A (en) * | 1987-05-27 | 1990-01-09 | Alza Corporation | Juxtaposed laminated arrangement |
| US4940465A (en) * | 1987-05-27 | 1990-07-10 | Felix Theeuwes | Dispenser comprising displaceable matrix with solid state properties |
| US5340590A (en) * | 1987-06-25 | 1994-08-23 | Alza Corporation | Delivery system with bilayer osmotic engine |
| US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
| US4915949A (en) * | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
| US5004613A (en) * | 1987-07-27 | 1991-04-02 | Mcneil-Ppc, Inc. | Oral sustained release pharmaceutical formulation and process |
| US4820522A (en) * | 1987-07-27 | 1989-04-11 | Mcneilab, Inc. | Oral sustained release acetaminophen formulation and process |
| US4915954A (en) * | 1987-09-03 | 1990-04-10 | Alza Corporation | Dosage form for delivering a drug at two different rates |
| US4814181A (en) * | 1987-09-03 | 1989-03-21 | Alza Corporation | Dosage form comprising fast agent delivery followed by slow agent delivery |
| US5019397A (en) * | 1988-04-21 | 1991-05-28 | Alza Corporation | Aqueous emulsion for pharmaceutical dosage form |
| US5024842A (en) * | 1988-04-28 | 1991-06-18 | Alza Corporation | Annealed coats |
| US5006346A (en) * | 1988-04-28 | 1991-04-09 | Alza Corporation | Delivery system |
| US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
| US5030456A (en) * | 1988-11-07 | 1991-07-09 | Alza Corporation | Dosage form for treating cardiovascular diseases |
| US5021053A (en) * | 1989-07-14 | 1991-06-04 | Alza Corporation | Oral osmotic device with hydrogel driving member |
| US5126142A (en) * | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore |
| US5221536A (en) * | 1990-05-07 | 1993-06-22 | Alza Corporation | Dosage form indicated for the management of abnormal posture, tremor and involuntary movement |
| US5417682A (en) * | 1991-01-30 | 1995-05-23 | Alza Corporation | Device for administering active agent to biological environment |
| US5190765A (en) * | 1991-06-27 | 1993-03-02 | Alza Corporation | Therapy delayed |
| GB9121204D0 (en) * | 1991-10-04 | 1991-11-20 | Euro Celtique Sa | Medicament |
| US5407686A (en) * | 1991-11-27 | 1995-04-18 | Sidmak Laboratories, Inc. | Sustained release composition for oral administration of active ingredient |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| US5286493A (en) * | 1992-01-27 | 1994-02-15 | Euroceltique, S.A. | Stabilized controlled release formulations having acrylic polymer coating |
| US5858407A (en) * | 1992-02-27 | 1999-01-12 | Alza Corporation | Method for administering tandospirone |
| US5512299A (en) * | 1992-03-30 | 1996-04-30 | Alza Corporation | Method of treating oral inflammatory disease |
| JP2796656B2 (ja) * | 1992-04-24 | 1998-09-10 | 三菱電機株式会社 | 半導体装置およびその製造方法 |
| US6210714B1 (en) * | 1993-11-23 | 2001-04-03 | Euro-Celtique S.A. | Immediate release tablet cores of acetaminophen having sustained-release coating |
| ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
| US5460826A (en) * | 1994-06-27 | 1995-10-24 | Alza Corporation | Morphine therapy |
| US5914131A (en) * | 1994-07-07 | 1999-06-22 | Alza Corporation | Hydromorphone therapy |
| US5529787A (en) * | 1994-07-07 | 1996-06-25 | Alza Corporation | Hydromorphone therapy |
| US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
| US6491945B1 (en) * | 1994-09-16 | 2002-12-10 | Alza Corporation | Hydrocodone therapy |
| US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
| US5534263A (en) * | 1995-02-24 | 1996-07-09 | Alza Corporation | Active agent dosage form comprising a matrix and at least two insoluble bands |
| US6110187A (en) * | 1995-02-24 | 2000-08-29 | Heartport, Inc. | Device and method for minimizing heart displacements during a beating heart surgical procedure |
| US5912268A (en) * | 1995-05-22 | 1999-06-15 | Alza Corporation | Dosage form and method for treating incontinence |
| DK0914097T3 (da) * | 1996-03-12 | 2002-04-29 | Alza Corp | Sammensætning og doseringsform omfattende opioid antagonist |
| US6586458B1 (en) * | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US6465016B2 (en) * | 1996-08-22 | 2002-10-15 | Research Triangle Pharmaceuticals | Cyclosporiine particles |
| US6919373B1 (en) * | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
| EP0914098B1 (en) * | 1997-05-30 | 2003-10-01 | Osmotica Corp. | Multi-layered osmotic device |
| PL340305A1 (en) * | 1997-11-03 | 2001-01-29 | Janssen Pharmaceutica Nv | Composition of agents reducing the level of lipoides |
| WO1999032095A1 (en) * | 1997-12-22 | 1999-07-01 | Alza Corporation | Rate controlling membranes for controlled drug delivery devices |
| BR9813826A (pt) * | 1997-12-22 | 2000-10-10 | Euro Celtique Sa | Potencial de uso abusivo de administração oral de opióide analgésico |
| SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
| FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
| EP1041968B1 (en) * | 1997-12-29 | 2004-03-03 | Alza Corporation | Osmotic delivery system with membrane plug retention mechanism |
| US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
| US6365183B1 (en) * | 1998-05-07 | 2002-04-02 | Alza Corporation | Method of fabricating a banded prolonged release active agent dosage form |
| US6252338B1 (en) * | 1998-05-21 | 2001-06-26 | General Electric Company | Reflector lamp having a reflecting section with faceted surfaces |
| US6254891B1 (en) * | 1998-09-03 | 2001-07-03 | Ascent Pediatrics, Inc. | Extended release acetaminophen |
| US6174547B1 (en) * | 1999-07-14 | 2001-01-16 | Alza Corporation | Dosage form comprising liquid formulation |
| US20010031279A1 (en) * | 1998-11-02 | 2001-10-18 | Evangeline Cruz | Controlled delivery of antidepressants |
| CN1325301A (zh) | 1998-11-02 | 2001-12-05 | 阿尔扎有限公司 | 活性物质的控制释放 |
| EP1005863A1 (en) * | 1998-12-04 | 2000-06-07 | Synthelabo | Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof |
| US6342249B1 (en) * | 1998-12-23 | 2002-01-29 | Alza Corporation | Controlled release liquid active agent formulation dosage forms |
| ATE433318T1 (de) * | 1999-02-10 | 2009-06-15 | Pfizer Prod Inc | Osmotisches system zur verabreichung von wirkstoffen, die feste amorphe dispersionen enthalten |
| DE19915420A1 (de) * | 1999-04-06 | 2000-10-12 | Basf Ag | Stabilisierte Polyvinylpyrrolidon-Zubereitungen |
| US20020071863A1 (en) * | 1999-12-09 | 2002-06-13 | Dong Liang C. | Antiviral medication |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| EA005537B1 (ru) * | 2001-07-10 | 2005-04-28 | Тева Фармасьютикал Индастриес Лтд. | Система доставки лекарственного вещества по нулевому порядку, нулевому порядку - двухстадийной, возрастающей или убывающей доставки препарата |
| GB0117618D0 (en) * | 2001-07-19 | 2001-09-12 | Phoqus Ltd | Pharmaceutical dosage form |
| US20030092724A1 (en) * | 2001-09-18 | 2003-05-15 | Huaihung Kao | Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic |
| US6893660B2 (en) * | 2002-11-21 | 2005-05-17 | Andrx Pharmaceuticals, Inc. | Stable pharmaceutical compositions without a stabilizer |
| CN1897924B (zh) * | 2003-09-26 | 2011-09-21 | 阿尔扎公司 | 能提供高载药量的药物包衣和提供它的方法 |
| MXPA06003454A (es) * | 2003-09-26 | 2006-08-31 | Johnson & Johnson | Formulaciones de liberacion controlada de analgesicos opioides y no opiodes. |
-
2004
- 2004-09-24 NZ NZ586198A patent/NZ586198A/en not_active IP Right Cessation
- 2004-09-24 DE DE602004032149T patent/DE602004032149D1/de not_active Expired - Lifetime
- 2004-09-24 EP EP04785033A patent/EP1663145B1/en not_active Expired - Lifetime
- 2004-09-24 CA CA002540047A patent/CA2540047A1/en not_active Abandoned
- 2004-09-24 WO PCT/US2004/031475 patent/WO2005030166A1/en not_active Ceased
- 2004-09-24 AT AT04785033T patent/ATE504288T1/de not_active IP Right Cessation
- 2004-09-24 US US10/949,180 patent/US20050089570A1/en not_active Abandoned
- 2004-09-24 KR KR1020067008086A patent/KR20060115860A/ko not_active Abandoned
- 2004-09-24 AU AU2004275826A patent/AU2004275826A1/en not_active Abandoned
- 2004-09-24 JP JP2006528249A patent/JP5670609B2/ja not_active Expired - Fee Related
- 2004-09-24 MX MXPA06003453A patent/MXPA06003453A/es active IP Right Grant
-
2006
- 2006-03-26 IL IL174562A patent/IL174562A0/en not_active IP Right Cessation
- 2006-04-26 NO NO20061859A patent/NO20061859L/no not_active Application Discontinuation
-
2010
- 2010-01-06 US US12/683,283 patent/US20100196425A1/en not_active Abandoned
-
2011
- 2011-03-29 AU AU2011201429A patent/AU2011201429A1/en not_active Abandoned
-
2014
- 2014-10-16 JP JP2014212033A patent/JP2015034168A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007506774A5 (OSRAM) | ||
| CA2540047A1 (en) | Oros push-stick for controlled delivery of active agents | |
| JP2007506775A5 (OSRAM) | ||
| TWI583384B (zh) | 包含４－胺基－５－氟－３－［６－（４－甲基哌嗪－１－基）－１ｈ－苯并咪唑－２－基］－１ｈ－喹啉－２－酮乳酸鹽單水合物之醫藥組合物 | |
| EP1100470B1 (en) | Fast dissolving ibuprofen containing compositions having analgesic activity | |
| JPS62106011A (ja) | 徐放性錠剤 | |
| US20080027032A1 (en) | Combinations comprising cox-2 inhibitors and aspirin | |
| JP2005531570A (ja) | 貫粘膜薬物送達及び凍結保護のための組成物及び方法 | |
| CA2301378A1 (en) | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin | |
| CO5060477A1 (es) | Forma de dosificacion de nefazodona | |
| TW200407175A (en) | Dosage form of sodium IBUPROFEN | |
| JP7705862B2 (ja) | アゴメラチンを含有する経粘膜治療システム | |
| JPH05246845A (ja) | イブプロフェン含有解熱鎮痛剤 | |
| KR101113005B1 (ko) | 비-스테로이드계 항염증성 약물 투여법 | |
| JP2011046666A (ja) | 医薬組成物 | |
| JPWO2002066030A1 (ja) | ジクロフェナクとオルノプロスチルからなる医薬組成物 | |
| KR20170086053A (ko) | 디메틸 푸마르산염을 포함하는 제약학적 매트릭스 제제 | |
| EP2954895B1 (en) | Pharmaceutical combinations of controlled release flurbiprofen and diacerein | |
| IE840856L (en) | Pharmaceutical composition comprising dipyridamole | |
| WO2021132302A1 (ja) | 透析移行又は腎死の抑制のための薬剤 | |
| WO2014007777A1 (en) | Combined capsule formulations of nsaids | |
| US20150224056A1 (en) | Pharmaceutical compositions of ibuprofen and famotidine | |
| WO2014007778A1 (en) | COMBINED IMMEDIATE RELEASE FORMULATIONS OF NSAIDs | |
| JPH10226650A (ja) | グリチルリチン経口投与製剤 | |
| EP2797583B1 (en) | Combined pharmaceutical formulation containing diacerein |